Pain between the shoulder blades is a frequent complaint that can arise from a variety of factors, some minor and others more ...

The American College of Cardiology has recognized Woodlawn Hospital by awarding it the Chest Pain Center Certification for Critical Access Hospitals. The award, which the hospital received in December ...

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from ...

BACKGROUND Guillain-Barre syndrome (GBS) commonly presents with motor weakness and neurological symptoms and signs that include loss of tendon reflexes. However, patients with GBS also experience ...

Nonoperative treatment, such physical therapy, is the typical approach to treating rotator-cuff tears. However, surgery is considered in certain patients whose rotator-cuff tears don't resolve with ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The new drug is intended for treatment of moderate to severe acute pain in adults. Patients with acute pain after surgery or due to a broken bone or an injury are often prescribed opioid ...

It’s not an opioid, so it’s not addictive. That’s a breakthrough, because an estimated 3% to 19 percent of people who take prescription pain medications develop an addiction to them. And when the ...

(ABC 6 News) — The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid. The drug is called Journavx, and it is taken orally twice per day.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...